Peer Review reports
From: Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma
| Original Submission | ||
|---|---|---|
| 22 Dec 2019 | Submitted | Original manuscript |
| 2 Jan 2020 | Reviewed | Reviewer Report |
| 12 Mar 2020 | Reviewed | Reviewer Report |
| 31 Mar 2020 | Reviewed | Reviewer Report |
| 24 Apr 2020 | Author responded | Author comments - Noemi García-Romero |
| 27 Apr 2020 | Reviewed | Reviewer Report |
| 27 Apr 2020 | Reviewed | Reviewer Report |
| 28 Apr 2020 | Author responded | Author comments - Noemi García-Romero |
| Resubmission - Version 2 | ||
| 24 Apr 2020 | Submitted | Manuscript version 2 |
| Publishing | ||
| 29 Apr 2020 | Editorially accepted | |
| 22 Jun 2020 | Article published | 10.1186/s12916-020-01610-0 |
You can find further information about peer review here.